Optiver Holding B.V. »

Rapport Therapeutics shares owned by Optiver Holding B.V.

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Optiver Holding B.V. from 13F filings

Historical chart of Optiver Holding B.V. investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Optiver Holding B.V. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Optiver Holding B.V.

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.1k 106 29.70

More positions owned by Optiver Holding B.V.

Spdr S&p 500 Etf Tr Tr Unit Put Option
Spdr S&p 500 Etf Tr Tr Unit Call Option
Invesco Qqq Tr Unit Ser 1 Put Option
Invesco Qqq Tr Unit Ser 1 Call Option
Tesla Motors Inc cmn Call Option
Spdr Gold Tr Gold Shs Call Option
Nvidia Corp option Put Option
Tesla Motors Inc cmn Put Option
Spdr Gold Tr Gold Shs Put Option
Nvidia Corp option Call Option
Ishares Tr Msci Eafe Etf Put Option
On Semiconductor Corporation Put Option
Ishares Tr Msci Eafe Etf Call Option
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Dow Jones Indl Average Ut Ser 1 Put Option

View all positions for Optiver Holding B.V.

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
Sofinnova Ventures
Johnson & Johnson
Vanguard Group
BlackRock
Baker Bros. Advisors
Siren
Trv Gp Vi
Vestal Point Capital
Polar Capital Holdings

View all funds holding Rapport Therapeutics